The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Anticholinergic Activity of 107 Medications Commonly Used by Older Adults
Abstract
The objective of this study was to measure the anticholinergic activity (AA) of medications commonly used by older adults. A radioreceptor assay was used to investigate the AA of 107 medications. Six clinically relevant concentrations were assessed for each medication. Rodent forebrain and striatum homogenate was used with tritiated quinuclidinyl benzilate. Drug‐free serum was added to medication and atropine standard‐curve samples. For medications that showed detectable AA, average steady‐state peak plasma and serum concentrations ( C max ) in older adults were used to estimate relationships between in vitro dose and AA. All results are reported in pmol/mL of atropine equivalents. At typical doses administered to older adults, amitriptyline, atropine, clozapine, dicyclomine, doxepin, L‐hyoscyamine, thioridazine, and tolterodine demonstrated AA exceeding 15 pmol/mL. Chlorpromazine, diphenhydramine, nortriptyline, olanzapine, oxybutynin, and paroxetine had AA values of 5 to 15 pmol/mL. Citalopram, escitalopram, fluoxetine, lithium, mirtazapine, quetiapine, ranitidine, and temazepam had values less than 5 pmol/mL. Amoxicillin, celecoxib, cephalexin, diazepam, digoxin, diphenoxylate, donepezil, duloxetine, fentanyl, furosemide, hydrocodone, lansoprazole, levofloxacin, metformin, phenytoin, propoxyphene, and topiramate demonstrated AA only at the highest concentrations tested (patients with above‐average C max values, who receive higher doses, or are frail may show AA). The remainder of the medications investigated did not demonstrate any AA at the concentrations examined. Psychotropic medications were particularly likely to demonstrate AA. Each of the drug classifications investigated (e.g., antipsychotic, cardiovascular) had at least one medication that demonstrated AA at therapeutic doses. Clinicians can use this information when choosing between equally efficacious medications, as well as in assessing overall anticholinergic burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ancelin, M. L., Artero, S., Portet, F., Dupuy, A.-M., Touchon, J., & Ritchie, K. (2006) · BMJ · doi:10.1136/bmj.38740.439664.de · Cited by 589
Han, L., McCusker, J., Cole, M., Abrahamowicz, M., Primeau, F., & Élie, M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.8.1099 · Cited by 446
Starr, J. M. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.70 · Cited by 434
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.10.1393 · Cited by 316
Mulsant, B. H., Pollock, B. G., Kirshner, M., Shen, C., Dodge, H., & Ganguli, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.198 · Cited by 279
Self-citationThe Association of Serum Anticholinergic Activity With Delirium in Elderly Medical Patients
Flacker, J. M., Cummings, V., Mach, J. R., Bettin, K., Kiely, D. K., & Wei, J. (1998) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199800610-00005 · Cited by 246
Lechevallier‐Michel, N., Molimard, M., Dartigues, J., Fabrigoule, C., & Fourrier‐Réglat, A. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02232.x · Cited by 207
Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
Molchan, S. E., Martinez, R. A., Hill, J. L., Weingartner, H. J., Thompson, K., Vitiello, B., & Sunderland, T. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90017-g · Cited by 187
Tune, L. E., & Egeli, S. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017167 · Cited by 184
Serum Levels of Anticholinergic Drugs in Treatment of Acute Extrapyramidal Side Effects
Tune, L. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780160063007 · Cited by 181
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Pharmacological Management of Persistent Pain in Older Persons
(2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00699.x · Cited by 916
Fox, C., Richardson, K., Maidment, I. D., Savva, G. M., Matthews, F. E., Smithard, D., Coulton, S., Katona, C., Boustani, M. A., & Brayne, C. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03491.x · Cited by 655
Salahudeen, M. S., Duffull, S. B., & Nishtala, P. S. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0029-9 · Cited by 547
Systematic review of anticholinergic risk scales in older adults
Durán, C. E., Azermai, M., & Vander Stichele, R. H. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1499-3 · Cited by 369
Metadata
- Authors
- Chew, M. L., Mulsant, B. H., Pollock, B. G., Lehman, M. E., Greenspan, A., Mahmoud, R. A., Kirshner, M. A., Sorisio, D. A., Bies, R. R., & Gharabawi, G.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2008-07
- Volume
- 56
- Issue
- 7
- Pages
- 1333-1341
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2140009431
- Cited by
- 497
- References
- 30
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anticholinergic Activity of 107 Medications Commonly Used by Older Adults. https://app.cochat.ai/papers/10.1111/j.1532-5415.2008.01737.x
- The paper
- Chew, M. L., Mulsant, B. H., Pollock, B. G., Lehman, M. E., Greenspan, A., Mahmoud, R. A., Kirshner, M. A., Sorisio, D. A., Bies, R. R., & Gharabawi, G. (2008). Anticholinergic Activity of 107 Medications Commonly Used by Older Adults. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2008.01737.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.